Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oki

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1995
[An immunohistological study on expression of glutathione S-transferase pi (form) in human ovarian carcinoma]T Satoh, M Nishida, Y Miyazaki, et al.
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1995
[Analysis of familial aggregation of ovarian and breast cancer in patients with ovarian cancer]Y Ichikawa, M Nishida, M Sugita, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|August 12, 1999
[Risk assessment in urgent or emergent coronary artery bypass grafting for acute coronary syndrome]T Michihata, A Oki, K Iyano, et al.
British Journal of Cancer|September 11, 2008
Silent venous thromboembolism before treatment in endometrial cancer and the risk factorsT Satoh, K Matsumoto, K Uno, et al.
British Journal of Cancer|January 11, 2007
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerK Uno, S Homma, T Satoh, et al.
Rhinology|September 26, 2024
Omalizumab reduces allergic rhinitis symptoms due to Japanese cedar pollen by improving eosinophilic inflammationK Hirano, I Suzaki, N Okuzawa, et al.
British Journal of Cancer|September 27, 2007
High incidence of silent venous thromboembolism before treatment in ovarian cancerT Satoh, A Oki, K Uno, et al.
Nature Medicine|December 1, 1996
Tumor-specific autologous cytotoxic T lymphocytes from tissue sectionsS Q Liu, H Shiraiwa, K Kawai, et al.
British Journal of Cancer|August 17, 2013
Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomasA Akiyama-Abe, T Minaguchi, Y Nakamura, et al.
AJPM Focus|July 18, 2025
Understanding Vaccine Disparities in the Bronx, New York, Through a Mixed Methods Analysis of Community and Provider PerspectivesBrett I Bell, Sarah Hill, Justin Olivera, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1995
[An immunohistological study on expression of glutathione S-transferase pi (form) in human ovarian carcinoma]T Satoh, M Nishida, Y Miyazaki, et al.
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1995
[Analysis of familial aggregation of ovarian and breast cancer in patients with ovarian cancer]Y Ichikawa, M Nishida, M Sugita, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|August 12, 1999
[Risk assessment in urgent or emergent coronary artery bypass grafting for acute coronary syndrome]T Michihata, A Oki, K Iyano, et al.
British Journal of Cancer|September 11, 2008
Silent venous thromboembolism before treatment in endometrial cancer and the risk factorsT Satoh, K Matsumoto, K Uno, et al.
British Journal of Cancer|January 11, 2007
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerK Uno, S Homma, T Satoh, et al.
Rhinology|September 26, 2024
Omalizumab reduces allergic rhinitis symptoms due to Japanese cedar pollen by improving eosinophilic inflammationK Hirano, I Suzaki, N Okuzawa, et al.
British Journal of Cancer|September 27, 2007
High incidence of silent venous thromboembolism before treatment in ovarian cancerT Satoh, A Oki, K Uno, et al.
Nature Medicine|December 1, 1996
Tumor-specific autologous cytotoxic T lymphocytes from tissue sectionsS Q Liu, H Shiraiwa, K Kawai, et al.
British Journal of Cancer|August 17, 2013
Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomasA Akiyama-Abe, T Minaguchi, Y Nakamura, et al.
AJPM Focus|July 18, 2025
Understanding Vaccine Disparities in the Bronx, New York, Through a Mixed Methods Analysis of Community and Provider PerspectivesBrett I Bell, Sarah Hill, Justin Olivera, et al.
Pageof 6